Previously undetectable, quantified. One molecule at a time.

Powered by Singulex high-definition Single Molecule Counting (SMCTM) technology, you can measure low-abundance biomarkers accurately and reliably.

See how Singulex technology has been used as the solution of choice to accelerate discovery and uncover novel biology.

Case Study
Accelerating Drug Development and Clinical Validation through Ultrasensitive Immunoassay Technology

Application Note: Cardiotoxicity
Elevations of cardiac troponin-I quantified with the Erenna® cTnI immunoassay are an early indicator of heart muscle injury in studies of cardiotoxicity

Unless otherwise noted, Singulex products are for research use only and not intended for diagnostic use.

See more data now.